MaxCyte (MXCT)
Supplies ExPERT electroporation tools, consumables, licenses, and gene-editing assay services.
$1.24
After hours0.00 (0.00%)
At close$1.24(+1.64%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 50 days
EPS estimate
−$0.08
Revenue estimate
$7.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.10−$0.10−$0.12−$0.12−$0.06−$0.04−$0.08Pending
Estimate−$0.12−$0.10−$0.10−$0.11−$0.08−$0.10−$0.09−$0.08
Surprise+16.7%0.0%−20.0%−9.1%+25.0%+60.0%+11.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$8.7M$10.4M$8.5M$6.8M$7.3M$9.7M$7.3MPending
Estimate$9.3M$9.6M$10.4M$9.4M$9.1M$7.3M$6.5M$7.0M
Surprise−6.2%+8.6%−17.9%−27.4%−19.6%+32.5%+11.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.05 | — | — |
| Sep 2027 | −$0.07 | — | — |
| Jun 2027 | −$0.08 | — | — |
| Mar 2027 | −$0.07 | — | — |
| Dec 2026 | −$0.07 | — | — |
| Nov 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.09 | −$0.08 | +11.1% |
| May 2026 | −$0.10 | −$0.04 | +60.0% |
| Mar 2026 | −$0.08 | −$0.06 | +25.0% |
| Nov 2025 | −$0.11 | −$0.12 | −9.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.05 | — | — | $10.5M | — | — | — |
| Sep 2027 | −$0.07 | — | — | $9.5M | — | — | — |
| Jun 2027 | −$0.08 | — | — | $8.6M | — | — | — |
| Mar 2027 | −$0.07 | — | — | $8.1M | — | — | — |
| Dec 2026 | −$0.07 | — | — | $7.5M | — | — | — |
| Nov 11, 2026 | −$0.08 | — | — | $7.0M | — | — | — |
| Aug 12, 2026 | −$0.09 | −$0.08 | +11.1% | $6.5M | $7.3M | +11.8% | +9.5% |
| May 12, 2026 | −$0.10 | −$0.04 | +60.0% | $7.3M | $9.7M | +32.5% | +0.7% |
| Mar 24, 2026 | −$0.08 | −$0.06 | +25.0% | $9.1M | $7.3M | −19.6% | −6.8% |
| Nov 12, 2025 | −$0.11 | −$0.12 | −9.1% | $9.4M | $6.8M | −27.4% | −4.4% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 22, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 13, 2021 | |||||||
| Jul 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |